SCHEMBL6435776

SCHEMBL6435776

O=Cc1ccc(OC(F)(F)F)c([N+](=O)[O-])c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH5A1 P51649 1/20 0.53
▸ ABAT P80404 1/20 0.53
▸ VCAM1 P19320 1/20 0.53
▸ TTR P02766 1/20 0.50
▸ ALDH1A1 P00352 9/20 0.47
▸ MAPT P10636 6/20 0.47
▸ LMNA P02545 4/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ ALDH3A1 P30838 2/20 0.46
▸ ALDH1A3 P47895 1/20 0.46
▸ CYP1A2 P05177 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ HPGD P15428 4/20 0.44
▸ TUBB4A P04350 1/20 0.43
▸ TUBB P07437 1/20 0.43
▸ TUBA3C P0DPH7 1/20 0.43
▸ TUBA1B P68363 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7626416 0.93 ALDH5A1 (0.47) ALDH5A1ABATVCAM1TTRALDH1A1
SCHEMBL28087611 0.88 ALDH5A1 (0.49) ALDH5A1ABATVCAM1TTRALDH1A1
SCHEMBL16953837 0.86 TUBB4A (0.43) ALDH5A1ABATVCAM1TTRALDH1A1
SCHEMBL16953042 0.86 CRHBP (0.44) ALDH5A1ABATVCAM1TTRALDH1A1
SCHEMBL1414586 0.85 ALDH5A1 (0.48) ALDH5A1ABATVCAM1TTRALDH1A1
SCHEMBL1414587 0.81 ALDH1A1 (0.51) ALDH5A1ABATVCAM1TTRALDH1A1
SCHEMBL346541 0.79 TUBB4A (0.66) ALDH5A1ABATVCAM1TTRALDH1A1
SCHEMBL1275605 0.79 HSPB1 (0.51) MAPTLMNAKMT2AHTTCRHBP
SCHEMBL397137 0.79 HSPB1 (0.56) TTRALDH1A1MAPTLMNAMEN1
SCHEMBL30062398 0.79 HSPB1 (0.56) TTRALDH1A1MAPTLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106170486-A Novel indazolecarboxamides, method for the production thereof, pharmaceutical preparations containing the same and use thereof for producing medicaments 拜耳医药股份有限公司 2016-11-30 — — CN disclosed
EP-1194429-B1 POTASSIUM CHANNEL OPENERS ABBOTT LAB (US) 2005-03-30 — — EP disclosed
US-6593335-B1 Disease than can be ameliorated with a potassium channel opener in a host mammal, comprising administering to the mammal in need thereof a therapeutically effective amount of the compound of claim 1; said disease is epilepsy, Raynaud's ABBOTT LABORATORIES 2003-07-15 — — US disclosed
Send feedback